Title Credit Type Event date Cost
Ace the Case Challenge Series: The Intersection of MASH and Cardiometabolic Risk
    • 0.50 CDE
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
The Burden of Resistant Hypertension in Women: Novel and Emerging Approaches to Improve Outcomes
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
A New Wave of Topical Therapies for Atopic Dermatitis: Comparing Treatment Approaches
    • 1.00 AANP
    • 1.00 AAPA Category I CME
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
The Risk Stratification and Treatment of Chronic Kidney Disease in Women: Uncovering and Addressing Disparities to Improve Outcomes
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Podcast - Ironing Out the Data: Iron Deficiency in Heart Failure
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
Optimizing the Recognition and Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes: What Primary Care Clinicians Need to Know
    • 1.25 ACPE Pharmacy
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 ANCC
    • 1.25 Participation
 Enduring $0.00
Dietary Strategies for Reversing Type 2 Diabetes: Advances, Perspectives, and Expert Discussions
    • 4.00 Participation
 Enduring $0.00
PAINWeek 2024 Digital All Access
    • 80.00 ACCME (MD/DO Only)
    • 80.00 AANP
      • 31.00 AANP Pharmacology Hours
    • 80.00 APA
    • 80.00 ACCME (All Other)
      • 38.00 MATE ACT credit
    • 80.00 ACPE Pharmacy
    • 80.00 ANCC
 Enduring $899.00
Scratching the Surface of BTK Inhibition for Chronic Spontaneous Urticaria: Beyond Skin Deep
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
At the Forefront of Care for Patients with Worsening Heart Failure: New and Emerging Treatment Options
    • 1.25 ACPE Pharmacy
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 ANCC
    • 1.25 Participation
 Enduring $0.00
Addressing the Cardiometabolic Risk Continuum in MASH: What Clinicians Need to Know
    • 1.00 CDE
    • 1.00 ACPE Pharmacy
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 ANCC
    • 1.00 Participation
 Enduring $0.00
Clinical Brief: Advancements in Dyslipidemia Treatments and ASCVD Risk Reduction for High-Risk Individuals
    • 0.50 CDE
    • 0.50 ACPE Pharmacy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
Addressing Unmet Needs and Disease Burden in Chronic Spontaneous Urticaria: A Clinical Escape Room Challenge
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 ANCC
    • 0.50 Participation
 Enduring $0.00
JAK is Out of the Box: Leveling Up Care for Severe Alopecia Areata Across Patient Populations
    • 0.75 AAPA Category I CME
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 Participation
 Enduring $0.00
Expanding the AD Toolb-OX: A New Pathway for Treating Moderate-to-Severe Disease
    • 0.75 AAPA Category I CME
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 Participation
 Enduring $0.00

Pages